Binding of [3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: Potentiation by tranylcypromine
- 24 January 1997
- journal article
- Published by Elsevier in Life Sciences
- Vol. 60 (9) , 605-615
- https://doi.org/10.1016/s0024-3205(96)00639-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Imidazoline Receptors and Their Endogenous LigandsAnnual Review of Pharmacology and Toxicology, 1996
- Imidazoline/Guanidinium Binding Domains on Monoamine OxidasesJournal of Biological Chemistry, 1995
- Localization of I2-Imidazoline Binding Sites on Monoamine OxidasesJournal of Biological Chemistry, 1995
- Imidazoline receptors, non-adrenergic idazoxan binding sites and α2-adrenoceptors in the human central nervous systemNeuroscience, 1994
- Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down‐regulates non‐adrenoceptor [3H]‐idazoxan binding sites in the rat brainBritish Journal of Pharmacology, 1993
- A Second Generation of Centrally Acting Antihypertensive Agents Act on Putative I1-Imidazoline ReceptorsJournal of Cardiovascular Pharmacology, 1992
- Autoradiographic distribution of α2 adrenoceptors, NAIBS, and 5-HT1A receptors in human brain using [3H]idazoxan and [3H]rauwolscineBrain Research, 1991
- Identification of an imidazoline-guanidinium receptive site in mitochondria from rabbit cerebral cortexEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Clonidine binds to imidazole binding sites as well as α2-adrenoceptors in the ventrolateral medullaEuropean Journal of Pharmacology, 1987
- Role of the ventral surface of the brain stem in the hypotensive action of clonidineEuropean Journal of Pharmacology, 1975